Bile acids modulate gene expression by serving as ligands for the farnesoid X receptor (FXR), 1 which is a member of the nuclear receptor superfamily. They are produced in the liver as C-24 hydroxysteroid metabolites of cholesterol and serve as intestinal emulsifying agents for hydrophobic nutrients (1) (2) (3) . These cholesterol derivatives also function as the autoregulated sensor to modulate the expression of the enzymes and proteins that are involved in bile acid and cholesterol metabolism through enterohepatic re-absorption and fecal excretion. For example, bile acids repress expression of the gene for CYP7A1, the rate-limiting enzyme for the neutral pathway to bile acid biosynthesis, and for CYP8B, a 12␣-hydroxylase enzyme that routes the neutral pathway to cholic acid synthesis (2) (3) (4) (5) . Bile acids also direct their own uptake by negatively regulating the hepatic expression of the sodium/taurocholate cotransporter polypeptide, a basolateral protein that imports bile acids into hepatocytes from the sinusoidal blood (6) . On the other hand, bile acids induce the genes for the ileal bile acidbinding protein (IBABP), the bile salt efflux pump (BSEP), the phospholipid transfer protein (PLTP), and the inhibitory orphan receptor protein, known as the small heterodimer partner (SHP) (7) (8) (9) (10) (11) .
The ligand-activated FXR forms a heterodimer with the 9-cis-retinoic acid receptor (RXR) and directly interacts with the bile acid-responsive DNA element of the target gene (12) (13) (14) . The consensus DNA element for binding of the RXR/FXR heterodimer is an inverted repeat (IR) of the hexanucleotide (A/G)G(G/T)TCA, having the two half-sites separated by a single nucleotide (15) . This IR-1 arrangement is present in the bile acid response elements of IBABP, PLTP, BSEP, and SHP genes (7) (8) (9) (10) (11) . In contrast to its direct role in gene induction, the FXR signaling acts indirectly to cause feedback repression of CYP7A1 (3, 5, 10, 11) . In this case, the activated FXR induces SHP expression that in turn inhibits CYP7A1 gene transcription through functional interference with the fetoprotein transcription factor (FTF), which acts as a competence factor in the basal and oxysterol-induced expression of the CYP7A1 gene. Unlike the ubiquitous RXR, FXR has a restricted tissue distribution (5, 16) . FXR is expressed in the liver, intestine, and kidney, the same tissues that play critical roles in bile acid metabolism and thus need to respond to changes in the bile acid flux. Additionally, FXR is expressed in the adrenal cortex (5, 16) , where it may also be involved in the regulation of steroid-metabolizing enzymes.
Dehydroepiandrosterone-sulfotransferase, known as STD (or SULT2A1, recommended by the International Sulfotransferase Nomenclature Workshop) is a cytosolic enzyme that mediates sulfate conjugation of a number of hydroxysteroid substrates such as bile acids, pregnenolone, androgens, and estrogens (17) (18) (19) (20) (21) . Sulfo-conjugation of cholesterol itself appears to be mediated by two closely related members of the hydroxysteroid sulfotransferase family, bearing 48% amino acid sequence identity with STD (22, 23) . STD has the highest substrate affinity for dehydroepiandrosterone (DHEA), which is a C-19 steroid and precursor for testosterone. The genes encoding STD in the rat and human have been extensively characterized (24 -27) . STD is selectively expressed in the liver, small intestine, colon, and adrenal cortex (17, 18, 28 -31) . Interestingly, the same tissues also express FXR. Because of its bile acid sulfo-conjugating activity, STD is expected to be an important component of the cholesterol removal mechanism through fecal loss.
In this article, we show that the primary bile acid chenodeoxycholic acid (CDCA), a known ligand for FXR, is a potent inducer of the rat Std promoter and this induction is mediated through a response element located between Ϫ169 and Ϫ193 positions. Unlike the IR-1 arrangement of the RXR/FXR binding sites identified in the IBABP, BSEP, PLTP, and SHP genes, the Ϫ169/Ϫ193 site in the Std promoter contains an IR-0 motif as the FXR cognate element. Thus, the rat Std promoter provides the first example of an IR-0-containing FXR target gene. We speculate that increased solubility of sulfated bile acids facilitates their intracellular transport and clearance, thereby contributing to overall cholesterol homeostasis.
EXPERIMENTAL PROCEDURES
Enzyme Assay for Sulfotransferase Activity-Chenodeoxycholic acid, lithocholic acid, dehydroepiandrosterone, and 5␣-dihydrotestosterone, the substrates for the sulfotransferase enzyme, were purchased from Sigma. Recombinant, baculovirally produced DHEA-sulfotransferase was incubated with each substrate, and 35 S-labeled 3Ј-phosphoadenosine 5Ј-phosphosulfate (PAPS) (PerkinElmer Biosciences), which serves as the donor cofactor, in a 50-l reaction mixture using conditions described by us previously (19) . The sulfated products were separated from free [ 35 S]PAPS by extraction with ethyl acetate. The labeled products in the organic phase were recovered, dried, and taken up into 20 l of ethyl acetate. 5 l of this solution was used for direct scintillation counting. The rest was analyzed by thin layer chromatography (TLC) using silica gel impregnated on a glass fiber sheet. The TLC solvent consisted of CHCl 3 (100 ml), acetone (35 ml), and acetic acid (6 ml). At the end of the TLC run, the plate was air-dried and the sulfated products (displaced from the point of origin) were visualized by autoradiography.
Recombinant DHEA-sulfotransferase was produced in Sf9 insect cells from the AcMNPV baculoviral vector after the viral polyhedrin gene of AcMNPV was replaced by the full-length Std cDNA through homologous recombination (32) . The transfer vector pVL1393 (Invitrogen, CA), containing the Std cDNA cloned into the PstI site, and the AcMNPV baculoviral DNA (Invitrogen), were transfected into Sf9 cells. The cells were grown at 27°C for 4 days, and the progeny viral particles released into the culture medium were used to infect new Sf9 cells. The monolayer culture of infected Sf9 cells was overlaid with agarose, and the plates were incubated at 27°C in a humid chamber for 3 days to grow plaques. The occlusion body negative recombinant plaques were selected for the subsequent rounds of Sf9 cell infection to produce a high titer recombinant viral stock. This stock was used to infect fresh Sf9 cells, and the cells were cultured for 3 days to allow viral propagation. The cytosol of the harvested Sf9 cells was the source for recombinant Std. Immunoblot of the recombinant Sf9 cytosol and immunostaining of the recombinant Sf9 cells showed specific expression of Std.
Plasmid Constructs and, Site-directed Mutagenesis-The natural Std promoter-containing reporter construct (Ϫ366/ϩ38 Std-CAT) was described earlier (27) . The heterologous constructs (IR0)-TK-Luc and 3ϫ(IR0)-TK-Luc were prepared by cloning, respectively, a single copy and three tandemly repeated copies of the Ϫ169 to Ϫ193 sequence of the rat Std promoter into the 5Ј end of the TK promoter of the TK-Luc vector. We prepared TK-Luc by first removing the NF-B consensus element from the NF-B-TK-Luc plasmid (CLONTECH) using restriction digestion, and then an oligonucleotide sequence was ligated to the vector backbone to create multiple cloning sites. The Ϫ169/Ϫ193 oligonucleotide duplex as a single copy was cloned into the TK-Luc plasmid via KpnI and BglII sites. Three copies of the Ϫ169/Ϫ193 sequence in a tandem repeat were cloned into TK-Luc via MluI and BglII sites. Oligonucleotides with appropriate restriction sites at 5Ј and 3Ј ends were custom synthesized commercially. The mutant construct (IR0)mut-TK-Luc was engineered by ligating one copy of an oligonucleotide containing 3-base mutations within the IR-0 of the Ϫ169/Ϫ193 element (CAT 3 ACC) to TK-Luc. The constructs were verified by DNA sequencing.
Cell Transfection and Analysis of Reporter Expression-HepG2 and Caco-2 cells (ATCC) were propagated using the minimum essential medium in the presence of 5% fetal bovine serum. Cells at ϳ0.6 ϫ 10 6 /well (12-well flasks) were seeded overnight in Dulbecco's modified Eagle's medium containing 5% charcoal-stripped serum (Life Technologies, Inc.) and transfected with 1 g of reporter construct and 100 ng each of FXR and RXR-␣ expression plasmid using the Fugene (Roche Molecular Biochemicals) transfection reagent. In certain cases, transfection included only the FXR or the RXR-␣ expression plasmid alone and the reporter plasmid. The total amount of DNA in all transfection experiments was kept constant (1.5 g) by supplementing with the empty vector (pcDNA3). One hour after Fugene-mediated DNA transfer, the cells were treated with CDCA or vehicle (ethanol) and harvested at 40 h after transfection. CDCA was dissolved in 50% ethanol, the final ethanol in all wells being at 0.01%. Cell extracts were assayed for either the CAT activity or the luciferase activity, using CAT enzyme-linked immunosorbent assay kit (Roche Molecular Biochemicals) and luciferase assay kit (Promega, Madison, WI), respectively. Protein concentrations were determined by the Bradford assay (33). Reporter expression was normalized to constant protein amounts.
DNase 1 Footprinting, Electrophoretic Gel Mobility Shift Assay, and Antibody Supershift-The probe for DNase 1 footprinting was generated by polymerase chain reaction amplification of the Std promoter region between Ϫ215 and Ϫ115 positions. The coding strand was radiolabeled using a 32 P-labeled sense primer and an unlabeled antisense primer. The labeled polymerase chain reaction product was purified electrophoretically on a 1% agarose gel, and the DNA probe was recovered from the gel using a DNA extraction kit (Novagen, CA). The DNA fragment radiolabeled at the 5Ј end of the sense strand (ϳ10 fmol and 50,000 cpm) was incubated with 50 g of liver nuclear extracts (27) ; after organic extraction, the digested DNA fragments were analyzed on a sequencing gel. The rat liver nuclear extract was prepared as detailed previously (27) . Bovine serum albumin was used in the control experiment to produce the unprotected ladder pattern from DNase 1-digested fragments, and in this case 10-fold less DNase 1 was used. For oligonucleotide competition of the Ϫ169/Ϫ193 footprint, the binding reaction contained at 300-fold molar excess either the homologous oligo duplex (Ϫ169/Ϫ193) or the heterologous Ϫ32/Ϫ55 hepatocyte nuclear factor (HNF) 1 element in the Std promoter. This HNF-1 element has been described elsewhere (27) .
Electrophoretic mobility shift assay (EMSA) was performed by incubating the liver nuclear extract (5 g) or in vitro translated FXR and RXR-␣ with the 32 P-labeled Ϫ169/Ϫ193 oligonucleotide duplex under standard binding conditions, and the protein-DNA complex was electrophoretically resolved from the free probe on a 5% nondenaturing gel. In vitro translated rat FXR and mouse RXR-␣ were prepared using a TNT rabbit reticulocyte system (Promega), and translated FXR and RXR-␣ (1 l each) were used in the EMSA binding reaction. For competition of the EMSA complex with the liver nuclear extract, the unlabeled homologous or heterologous duplex oligos at 100-fold molar excess were added during pre-incubation. When the recombinant FXR and RXR-␣ were used in the EMSA, the competing wild type and mutant oligos were used at 50-and 200-fold molar excess, and the heterologous NFB oligo was used at 200-fold molar excess. The nuclear extract was pre-incubated with the antibody for 10 min before addition of the DNA probe in the supershift assay. Antibodies to FXR (2 mg/ml; sc-1204X) and RXR-␣ (2 mg/ml; sc-774X) were from Santa Cruz Biotechnology (Santa Cruz, CA).
RESULTS
The Bile Acid Sulfating Activity of STD-Earlier studies with STD expressed in the liver cytosol have suggested that this sulfotransferase enzyme converts both DHEA and bile acids/salts to their sulfated derivatives (20, 34) . To further demonstrate that STD is indeed a bile acid sulfotransferase, we have used baculovirally produced recombinant enzyme to examine its activity toward primary and secondary bile acids in an in vitro enzyme assay. The sulfated products were visualized on a TLC autoradiogram (Fig. 1) . As test substrates, we used two C-24 bile acids, i.e. CDCA (a dihydroxy primary bile acid) and lithocholic acid (LCA, a monohydroxy secondary bile acid). Dehydroepiandrosterone (DHEA) and 5␣-dihydrotestosterone (5␣-DHT), the two C-19 steroids, were used as the positive control substrates. The reaction utilized [ 35 S]PAPS as the donor cofactor. The radiolabeled sulfated products were recovered as described under "Experimental Procedures" and resolved by TLC. The TLC autoradiogram shows that recombinant sulfotransferase can convert CDCA and LCA to the corresponding sulfo-conjugated forms. The migration rates of sulfated LCA and DHEA were similar, whereas sulfated CDCA migrated much more slowly with the TLC solvent system used in this experiment. Sulfated 5␣-DHT showed an intermediate migration rate. We analyzed an aliquot of each reaction product by liquid scintillation counting for incorporated radioactivity into the sulfated products to quantitatively assess the efficiency of the substrates as sulfate acceptors. Sulfo-conjugation of CDCA and LCA was about 25% as efficient as DHEA under the in vitro assay conditions used in this study. These results demonstrate conclusively that DHEA-sulfotransferase can mediate sulfation of C-24 bile acids.
Bile Acid-mediated Induction of the Std Promoter and Mapping of a Bile Acid-responsive Region- Fig. 2A shows the effect of increasing concentrations of CDCA on reporter CAT expression from the (Ϫ366/ϩ38) Std-CAT promoter-reporter construct in transiently transfected HepG2 hepatoma cells with or without co-transfection of the FXR expression plasmid. In the absence of FXR co-transfection, CDCA was only weakly effective in increasing the Std promoter function over that in vehicle-treated cells. On the other hand, supplementation with the FXR expression vector led to an ϳ5-fold increase of the CDCA response with saturation at 25 M CDCA. Upon co-expression of FXR and RXR-␣, either CDCA (the FXR-specific ligand) or 9-cis-retinoic acid (RA) (the RXR-specific ligand) was almost equally effective in stimulating the promoter function (Fig. 2B) . This result concurs with the known permissive role of the RXR/FXR heterodimer in bile acid and retinoid signaling (35) . When the cells were treated simultaneously with CDCA and 9-cis-RA, the extent of induction was only slightly higher than that treated with either one of these ligands alone. These results indicate that a functional bile acid-responsive region is present between Ϫ366 and ϩ38 nucleotide positions of the Std promoter, and it can be activated by FXR in a ligand-dependent manner. 
35 S]PAPS and the recombinant Sf9 cytosol under buffer conditions as described previously (19) . The radiolabeled sulfated products were recovered by ethyl acetate extraction, subjected to thin layer chromatography, and visualized by autoradiography. As a negative control, the mock-infected nonrecombinant Sf9 cytosol was incubated with DHEA and [
35 S]PAPS. In this case, only background radioactivity (ϳ60 cpm) was associated with the recovered sulfated products, and thus the point of origin was devoid of any residual radioactivity spot in the autoradiogram. Chemical structures of the test substrates are shown.
To identify this response element, we conducted functional promoter assay with progressively 5Ј deleted Std promoter fragments. Upon analysis of different lengths of the Std promoter for CDCA-mediated induction in transfected HepG2 cells, we found that the Ϫ215 to ϩ38 and Ϫ366 to ϩ38 promoter fragments were induced by CDCA, whereas a shorter promoter deleted beyond Ϫ158 was unresponsive (Fig. 3) . From these results we conclude that the bile acid response region resides between Ϫ215 and Ϫ158 bp of the Std promoter.
Characterization of a RXR/FXR Binding Site within the Bile Acid-responsive Region-The RXR/FXR binding site (bile acid response element) was further narrowed down by footprinting analysis of the Ϫ215 to Ϫ158 region. Fig. 4 shows a footprint with the liver nuclear extract covering Ϫ169 to Ϫ193 and includes a palindromic sequence (GGGTCA TGAACT) from Ϫ178 to Ϫ189. This palindrome is an IR-0 of the consensus (A/G)G(G/T)TCA half-site. The specificity of the protein-DNA interaction at the footprinted sequence is evident from the oligonucleotide competition assay, which shows that the protection at the Ϫ169/Ϫ193 element was lost in the presence of the cold homologous oligo duplex (Fig. 4, lane 4) , but not the heterologous oligo sequence that corresponds to the HNF-1 element between positions Ϫ32 and Ϫ55 of the Std promoter (lane 3).
The RXR/FXR binding site was further substantiated by EMSA. Fig. 5A shows that, upon incubation of the 32 P-labeled Ϫ169/Ϫ193 element with the liver nuclear extract, a gel-retarded specific DNA-protein complex was formed (Fig. 5A, lane  1) . The retarded band was competed out by 100-fold molar excess of the unlabeled homologous oligo duplex (lane 2), but not by the heterologous consensus element for NF-B (lane 3), thus confirming the specificity of the protein-DNA complex. Antibody supershift assay showed that the retarded complex contains both FXR and RXR-␣ (Fig. 5A, lanes 5-8) . The nonimmune serum did not supershift the EMSA complex (lane 4). Furthermore, as shown in Fig. 5B , a mixture of recombinant FXR and RXR-␣, produced by in vitro transcription and translation of the corresponding cDNAs, yielded an EMSA complex when incubated with the 32 P-labeled Ϫ169/Ϫ193 oligo duplex (Fig. 5B, lane 4) . This complex was specifically competed out by the cold Ϫ169/Ϫ193 element, designated as Std IR0 (lanes 5 and 6) but not by the mutant Ϫ169/Ϫ193 element (Std IR0mut) and the heterologous NF-B element (lanes 7-9) . The Std IR0mut oligo contains 3-base substitutions (CAT 3 ACC) within the IR-0 of the Ϫ169/Ϫ193 element. The results in Figs. 2-5, taken together, lead us to conclude that the Ϫ169/Ϫ193 footprint constitutes a bile acid response element harboring a cognate site for the heterodimeric RXR-␣/FXR. Incomplete supershift of the retarded band by combined FXR and RXR-␣ antibodies (Fig. 5A, lane 8) suggests that other regulatory proteins are also possibly present as constituents of the multiprotein-DNA complex at the Ϫ169/Ϫ193 footprinted element.
That the Ϫ169/Ϫ193 sequence functions as a bile acid response element is confirmed, based on the results that this sequence can confer CDCA dependent induction on the heterologous TK promoter in FXR-and RXR-␣-co-transfected HepG2 cells (Fig. 6) . When a single copy of the Ϫ169/Ϫ193 element was used in the reporter construct (IR0)-TK-Luc, CDCA caused an ϳ2-fold increase in luciferase expression from the basal TK promoter, whereas point mutations of the IR-0 site led to a complete loss of the TK promoter induction in the mutant plasmid (IR0)mut-TK-Luc (Fig. 6, A and B) . Furthermore, a tandem repeat of three copies of this element in the reporter construct 3ϫ(IR0)-TK-Luc caused ϳ15-fold increase in the bile acid response of the TK promoter in HepG2 cells (Fig. 6C) . Thus, the Ϫ169/Ϫ193 element itself, without other interacting sites, can confer bile acid responsiveness to the minimal promoter.
From a physiological standpoint, both hepatocytes and intestinal epithelial cells play critical roles in bile acid metabolism, and, in addition to the liver, both FXR and STD are expressed in the small intestine and colon. We, therefore, examined whether bile acids can stimulate Std promoter function in an intestinal cell line. The Caco-2 cell line is derived from human colon adenocarcinoma and possesses certain enterocyte-like properties. Fig. 7 shows that the Ϫ366/ϩ38 Std promoter was induced by more than 3-fold in FXR-and RXR-␣-co-transfected Caco-2 cells upon treatment with CDCA (Fig. 7A) . Furthermore, the Ϫ169/Ϫ193 element caused CDCA-dependent induction of the heterologous TK promoter in Caco-2 cells, and the induction was lost when the IR-0 within the Ϫ169/Ϫ193 element was altered by point mutations (Fig. 7B) . CDCA-dependent induction of TK in the reporter construct 3ϫ(IR0)-TK-Luc increased by as much as 70-fold. Thus, both liver and intestinal cells harbor the necessary transcription factors for the expression of the Std gene under the direct control by the ligandactivated FXR.
DISCUSSION
Sulfo-conjugation of hydroxyl and amino groups by sulfotransferases is a commonly utilized metabolic pathway for detoxification of hormones, neurotransmitters, drugs, and xenobiotics (17, 36, 37) . Sulfotransferases in mammalian cells constitute a large family of at least 44 similar enzymes, each containing two active sites: one for the sulfate donor PAPS and the other for the acceptor substrates (17, 38, 39) . Individual members of this enzyme family display distinct, albeit somewhat broad, substrate specificity. STD, which was originally thought to be involved in the metabolism of C-19 hydroxysteroids and in the inactivation of androgenic hormones (40) , is now realized to be a multifunctional enzyme with substrate affinity for both bile acids and androgens. In the rodent liver, the high expression of Std during the androgen-insensitive state of the hepatic tissue in senescent males is thought to be a result of the efficient conversion of androgens to androgen sulfates, which are receptor-inactive (19, 40) . Although the exact role of bile acid sulfation is presently unknown, it is reasonable to speculate that sulfo-conjugation of bile acids will reduce their detergent properties, and at the same time enhance their aqueous solubility, thereby facilitating intracellular transport of these cholesterol catabolites. Sulfation may also aid in the fecal clearance of bile acids/salts and, consequently, cholesterol elimination from the body.
In the present study, we have shown that the recombinantly produced STD catalyzes sulfate conjugation of the dihydroxylated primary bile acid CDCA and the monohydroxy secondary bile acid LCA. Most importantly, we show that the promoter for the rat DHEA-sulfotransferase is induced by the primary bile acid CDCA in transfected liver and intestinal cell lines. Additionally, we observed that endogenous STD gene expression was stimulated ϳ2-fold in HepG2 and Caco-2 cells after CDCA treatment (data not shown). These results favor the speculation that sulfation may be a protective mechanism to help reduce the toxicity of high levels of bile acids and facilitate their intracellular transport and urinary and fecal clearance. The CDCA-dependent induction of the Std gene promoter is reminiscent of the self-regulatory mechanisms that are operational for a number of genes concerned with the synthesis, transport, and elimination of bile acids, thereby ensuring that the bile acid flux remains within an optimum range. FXR-mediated induction of the genes for IBABP and BSEP, the two proteins involved, respectively, in the intracellular trafficking of intestinal bile acids and bile acid/salt efflux out of the hepatocytes (4, 7, 41) , are anticipated responses to increased enterohepatic pools of these cholesterol catabolites. Stimulation of the PLTP gene by bile acids is thought to be important in the regulation of reverse cholesterol transport (9, 42) . Likewise, FXR-mediated repression of the genes for the bile acid uptake protein sodium/taurocholate cotransporter polypeptide and the bile acid biosynthetic enzymes serves to maintain optimal bile acid pools in the enterohepatic circulation (2, 3, 6) . The rat Std promoter, besides its positive regulation by the bile acid-activated FXR, is also negatively regulated by the androgen-activated androgen receptor (27, 43) . Thus, in a unique regulatory scheme, two principal substrates of this sulfotransferase, i.e. androgens and bile acids, are also the activating ligands for two members of the nuclear receptor superfamily (i.e. androgen receptor and FXR) that control the expression of this enzyme. Although such auto-regulatory loops have been extensively characterized for homeostatic schemes in prokaryotes (e.g. the classical lac operon), similar pathways to self-regulation in the mammalian system have not been clearly deciphered.
FXR functions as an obligate heterodimer with the 9-cisretinoic acid receptor (RXR) and regulates target gene expression by binding to an inverted repeat of a hexanucleotide sequence motif. The optimal DNA binding element for the RXR/ FXR heterodimer is an IR-1 sequence of the (A/G)G(G/T)TCA half-site, as ascertained from the analysis of the oligonucleotides that can be selectively amplified from a pool of random sequences after multiple rounds of binding to a mixture of recombinant RXR-␣ and FXR (15) . Initial reports on four natural target genes for FXR (IBABP, PLTP, SHP, and BSEP) revealed that all of them contain the functional FXR site with a single nucleotide spacer between the inverted hexanucleotide repeat (IR-1). However, our finding with the Std gene promoter extends this view to include an IR-0 palindrome (GGGTCA TGAACT) as an alternative binding modality for the RXR/FXR heterodimer. Two lines of evidence further established the role of this IR-0 motif in the bile acid response. 1) the Ϫ169/Ϫ193 element can confer CDCA-dependent induction of a heterologous promoter (thymidine kinase) in HepG2 and Caco-2 cells; 2) disruption of the IR-0 sequence by point mutations (GGGT-CATGAACT 3 GGGTACCGAACT) completely abrogated the CDCA-induced activity of the TK promoter.
Because only part of the EMSA complex at the Ϫ169/Ϫ193 element is recognized by the anti-FXR or anti-RXR-␣ antibody, it is likely that other transcription factors are also present in this complex. In preliminary antibody supershift analysis, we have found evidence for the presence of the orphan nuclear receptor HNF-4 in this EMSA complex. 2 Furthermore, the antisense sequence 5Ј-CCAAGTTCA within the Ϫ169/Ϫ193 site is similar to the consensus element YCAAGGYCR for FTF (4) . FTF serves as a competence factor in the oxysterol-induced CYP7A1 gene expression mediated by the liver X receptor and its heterodimeric partner RXR-␣; FTF is also required for the expression of CYP8b, the enzyme that directs production of cholic acid in the bile acid biosynthetic pathway. It is interesting to note that both HNF-4 and FTF are expressed in the liver and intestine (16) , the same two tissues that also express STD and FXR.
In conclusion, our results show that STD, a bile acid sulfotransferase, is induced by the primary bile acid CDCA in liver and intestinal cell lines via an IR-0 element cognate to the FXR/RXR-␣ heterodimer. The physiological role of this regulatory pathway remains to be clearly delineated. The Cyp27 null mice that are deficient in sterol 27-hydroxylase, the rate-limiting enzyme in the acidic pathway to CDCA synthesis, are reported to be severely deficient in bile acid pools (44) . These animals display hypercholesterolemia and hyperlipidemia similar to the human CYP27 deficiency syndrome. It will be of interest to determine the impact of Cyp27 deficiency on Std gene expression. Because the enterohepatic metabolic loop plays a critical role in bile acid/cholesterol homeostasis, further characterization of the role of FXR signaling in Std gene expression may be of considerable physiological significance.
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